Our Q1 FY'25 results announcement was followed by our quarterly global townhall, this time at our Bachupally campus in Hyderabad. Our CEO Erez Israeli led a discussion on our performance and priorities. Patrick Aghanian, CEO of our Europe business, walked colleagues through our recent acquisition of the global NRT portfolio of Nicotinell and related brands, signifying our growing global footprint in the consumer healthcare business. Our Global Head of Quality and Pharmacovigilance, Krishna Venkatesh, reminded us of the backbone of our work – safety and quality that go beyond mere compliance with regulations. As our joint venture subsidiary with Nestlé India – Dr. Reddy’s and Nestlé Health Science Ltd – prepares to go live, we were thrilled to host Suresh Narayanan, Chairman and MD of Nestlé India. He was joined by M V Ramana, CEO – Branded Markets; Sandeep Khandelwal, Head – India Business; and Shantaprasad Nagarmath, CEO of the JV subsidiary. Our Co-Chairman and MD, Prasad G V, fittingly ended the meeting by describing the values and building blocks of a great company – one that invests in doing things that others can’t do, and not just by doing things better than others. In the lively Q&A that followed, questions to the Management Council ranged from affordability and access to productivity, operations and strategy. As always, our townhall was accompanied by a display of our products and initiatives – Xlabs, our ideation and innovation workspace; sustainable superfoods and sustainably sourced lifestyle products; key OTC products; and volunteering opportunities for colleagues! #TeamworkIsDreamwork #GoodHealthCantWait #WeAreDrReddys
-
-
-
-
-
+3